Article
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Journal of clinical pathology - 1 Nov 2014
Ross J S, Wang K, Rand J V, Gay L, Presta M J, Sheehan C E, Ali S M, Elvin J A, Labrecque E, Hiemstra C, Buell J, Otto G A, Yelensky R, Lipson D, Morosini D, Chmielecki J, Miller V A, Stephens P J
Abstract excerpt
AIMS: Adrenocortical carcinoma (ACC) carries a poor prognosis and current systemic cytotoxic therapies result in only modest improvement in overall survival. In this retrospective study, we performed a comprehensive genomic profiling of 29 consecutive ACC samples to identify potential targets of therapy not currently searched for in routine clinical practice. METHODS: DNA from 29 ACC was sequenced to high,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
